Cardiovascular and Circulatory System Myocardial Infarction

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Myocardial Infarction Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Myocardial Infarction Projects
--Centocor, Inc.
--Bharat Biotech International Limited
--Dr Reddys Laboratories Ltd
--deCODE genetics Inc
--Inotek Pharmaceuticals, Inc
--FIBREX Medical Inc.
--Menarini Group
--KAI Pharmaceuticals Inc.
--Mitsubishi Tanabe Pharma Corporation
--Millennium Pharmaceuticals Inc
--Portola Pharmaceuticals, Inc.
--Novartis AG
--Schering-Plough Corp
--Radiant Medical, Inc
--Synvista Therapeutics, Inc.
--Speedel
--TargeGen, Inc.
--t2cure GmbH
--VM Discovery, Inc.
--ThromboGenics NV

--Top Companies in early stage Myocardial Infarction Projects
--Amorcyte Inc.
--Adenosine Therapeutics, LLC
--Athersys, Inc.
--Angiotech Pharmaceuticals Inc
--BioLineRx, Ltd.
--BioDiem Ltd
--CliniGenetics SA
--Cardax Pharmaceuticals, Inc.
--EpiCept Corp
--DMI BioSciences, Inc.
--FivePrime Therapeutics, Inc.
--Evolutec Group plc
--Minapharm Pharmaceuticals
--Hunter-Fleming Ltd
--StemPath, Inc.
--RegeneRx Biopharmaceuticals Inc
--ThromboGenics NV
--t2cure GmbH
--Xigen S.A.
--Warren Pharmaceuticals, Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View